Advertisement

Topics

CSD And EyeLock Partner To Deliver Leading Iris Biometric Access Control Solutions In Australia

05:12 EDT 8 Aug 2017 | PR Newswire

NEW YORK, Aug. 8, 2017 /PRNewswire/ -- EyeLock LLC, a leader of iris-based identity authentication solutions and a majority-owned subsidiary of VOXX International Corporation (Nasdaq: VOXX), today announced that it has entered into a partnership with CSD (Central Security Distribution), an Australian distributor of world-leading electronic security brands, to deliver EyeLock's product suite of hardware and software solutions to its broad customer base in Australia.

EyeLock's technology provides an unprecedented level of convenience and security with unmatched biometric accuracy, making it the most proven way to authenticate identity aside from DNA. EyeLock's proprietary iris authentication technology looks at more than 240 unique iris characteristics and provides a fast, user-friendly experience. EyeLock is one of the only companies in the world to utilize dual-eye authentication.

"We are excited to be working with CSD," said Anthony Antolino, Chief Marketing and Business Development Officer at EyeLock. "CSD's broad network across Australia, technical expertise, training capabilities, and proven track record for delivering security products will allow us to further expand our global reach in the rapidly growing biometric market."

EyeLock has achieved significant technological breakthroughs and solved integration challenges that have historically been a barrier to mass-market adoption of iris authentication technology. In addition, the Company's approach provides maximum flexibility by offering designs that have either on-board or host-based processing and illumination. Algorithm performance capabilities for speed and accuracy have been validated by Novetta, a leader in advanced analytics technology and independent biometric testing, as unmatched in the market. EyeLock's reference designs have working distances of up to 60 cm with a false accept rate of 1 in 1.5 million for single eye authentication and a false reject rate of less than 1%.

"We are very excited to partner with Eyelock in Australia," said Mark Edwards, General Manager of Products & Marketing at CSD. "EyeLock's iris identity authentication products are fast, cost effective, easy to use and in coming months will have a deep integration with Inner Range's Integriti Security & Access Control System."

About EyeLockEyeLock LLC, a majority owned subsidiary of Voxx International Corporation (NASDAQ: VOXX), is an acknowledged leader in advanced iris authentication for the Internet of Things (IoT), providing the highest level of security with EyeLock ID™ technology. Iris authentication is highly secure because no two irises are alike and the iris is the most accurate human identifier other than DNA. The company's significant IP portfolio, including more than 100 patents and patents pending, and proprietary technology enables the convenient and secure authentication of individuals across physical and logical environments. EyeLock's solutions have been integrated and embedded across consumer and enterprise products and platforms, eliminating the need for PINs and passwords. Corporations across the Fortune 500 recognize the level of security EyeLock provides due in part to its extremely low false acceptance rate, ease of use, and scalability. As a sponsor member of the FIDO (Fast IDentity Online) Alliance, a non-profit organization dedicated to creating a safer and more secure digital presence for consumers, EyeLock is dedicated to advancing digital privacy and next generation security. For more information, please visit www.eyelock.com.

CONTACT:Anthony Antolino
914-619-5548
kgraham@eyelock.com

View original content:http://www.prnewswire.com/news-releases/csd-and-eyelock-partner-to-deliver-leading-iris-biometric-access-control-solutions-in-australia-300500967.html

SOURCE EyeLock LLC

NEXT ARTICLE

More From BioPortfolio on "CSD And EyeLock Partner To Deliver Leading Iris Biometric Access Control Solutions In Australia"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...